Veterinary Medicines

Castorex NEO suspension for injection for rabbits

Authorised
  • Rabbit haemorrhagic disease virus, type 2, strain F/12B, Inactivated
Download as PDF

Product identification

Medicine name:
Castorex NEO suspension for injection for rabbits
Castorex NEO Zawiesina do wstrzykiwań
Active substance:
  • Rabbit haemorrhagic disease virus, type 2, strain F/12B, Inactivated
Target species:
  • Rabbit
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabbit haemorrhagic disease virus, type 2, strain F/12B, Inactivated
    0.30
    enzyme-linked immunosorbent assay unit
    /
    500.00
    microlitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Rabbit
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI08AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • Paper carton containing glass vial made of neutral borosilicate glass with high hydrolytic resistance (Type 1) closed with a rubber plug suitable for parenteral preparations and an aluminium cap. (1x40 doses)
  • Paper carton containing glass vial made of neutral borosilicate glass with high hydrolytic resistance (Type 1) closed with a rubber plug suitable for parenteral preparations and an aluminium cap. (1x20 doses)
  • Paper carton containing glass vial made of neutral borosilicate glass with high hydrolytic resistance (Type 1) closed with a rubber plug suitable for parenteral preparations and an aluminium cap. (1x10 doses)
  • Paper carton containing glass vial made of neutral borosilicate glass with high hydrolytic resistance (Type 1) closed with a rubber plug suitable for parenteral preparations and an aluminium cap. (10x1 dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharmagal Bio spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmagal Bio spol. s r.o.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 3008
Date of authorisation status change:
Reference member state:
  • Slovakia
Procedure number:
  • SK/V/0109/001
Concerned member states:
  • Czechia
  • Hungary
  • Malta
  • Poland